Hyperphosphatemia – the value and methods of correction

DOI: https://dx.doi.org/10.18565/nephrology.2019.2.69-75

E.V. Shutov, S.M. Sorokoletov

1) SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department", Moscow, Russia; 2) FSBEI FPE "Russian Medical Academy of Continuous Professional Education" of the Ministry of Health of the Russian Federation, Moscow, Russia
In the review discusses mechanisms of regulation of phosphorus levels in the blood. The importance of hyperphosphatemia for the development of complications in patients with CKD. Methods of correction of phosphorus balance disorders.
Keywords: hyperphosphatemia, chronic kidney disease, phosphate-binding drugs, fibroblast growth factor, Clotho protein

About the Autors

Shutov E.V. – Doctor of Medical Sciences, Head of the Department of Nephrology № 12 SBHCI "CCH n.a. S.P. Botkin of Moscow Healthcare Department", Professor at the Department of Nephrology and Hemodialysis, FSBEI FPE RMACPE; Moscow, Russia. E-mail: shutov_e_v@mail.ru
Sorokoletov S.M. – Doctor of Medical Sciences, Deputy chief doctor SBHCI "CCH n.a. S.P. Botkin of Moscow Healthcare Department"; Moscow, Russia.

Бионика Медиа